Deciphera Receives European Commission Approval of QINLOCK® for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor – QINLOCK Significantly Reduced the Risk of Disease Progression or Death by 85% and Showed Clinically Meaningful Overall Survival in the...
PDS Biotechnology Licenses Protein for the Treatment of Acute Myeloid Leukemia, Prostate and Breast Cancers from National Cancer Institute Advances Next Phase of Versamune® Oncology Pipeline FLORHAM PARK, N.J., Nov. 08, 2021 (GLOBE NEWSWIRE) — PDS Biotechnology...
Aptinyx Completes Enrollment in Phase 2b Study of NYX-2925 in Painful Diabetic Peripheral Neuropathy Results from the Phase 2b study are expected in early to mid 2Q 2022 EVANSTON, Ill.–(BUSINESS WIRE)– Aptinyx Inc. (Nasdaq: APTX), a clinical-stage...
Kit Check Enters into a Reseller Agreement with Govplace to allow Government Hospitals to increase Pharmacy Visibility with RFID Enabled Kit and Tray Processing to Increase Medication Intelligence WASHINGTON (September 22, 2021) — Kit Check, the leader in automated...
TigerConnect’s Alarm Management and Event Notification Solution Mitigates “Alarm Fatigue” in Demanding Clinical Environments FDA-cleared solution enables converged healthcare communication and collaboration for providers struggling with staffing shortages and...
CLEERLY APPOINTS JIM HARTMAN AS CHIEF REVENUE OFFICERSales strategy expert brings industry success to leverage growth. NEW YORK – October 18, 2021 – Cleerly, the company creating a new standard of care for heart disease, announced today it has appointed Jim Hartman as...
Recent Comments